Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q3 FY22 results · Oct–Dec 2021
Bajaj Healthcare reported revenue from operations of ₹167.57 crore (down 6.0% from Q3 FY21) and net profit of ₹17.45 crore (down 34.0% from Q3 FY21) for Q3 FY22 (Oct–Dec 2021), on a standalone basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 167.57 | 178.33 | −6.0% | 150.91 | +11.0% |
| Other income | 0.20 | 1.76 | −88.8% | 0.12 | +67.3% |
| Total income | 167.77 | 180.10 | −6.8% | 151.03 | +11.1% |
| Profit before tax | 23.33 | 39.94 | −41.6% | 22.18 | +5.2% |
| Net profit for the period | 17.45 | 26.42 | −34.0% | 17.25 | +1.1% |
| EPS, basic (₹) | 6.32 | 19.15 | not comparable | 6.25 | +1.1% |
| Net margin (%) | 10.4 | 14.8 | 11.4 |
Standalone
- Filed with BSE
- 28 Jan 2022, 17:29 IST
- Board meeting
- 28 Jan 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE